New hybrid custom-designed Microscope Can Image Full 3D Orientation & Position of Molecules in Cells
On Feb. 21, 2025, a team of researchers from the Marine Biological Laboratory (MBL) announced a hybrid custom-designed…
-
-
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
On Feb. 18, 2025, Hologic announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance…
-
Novartis acquires Anthos Therapeutics and late-stage cardiovascular pipeline for USD $3.1 billion
On Feb. 11, 2025, Novartis announced an agreement to acquire Anthos Therapeutics, a Boston-based, privately held, clinical-stage biopharmaceutical…
-
Biotechnology | Disease | Genomics | Oncology | Therapeutics
Mutations in two gene pairs point to a promising drug target in 5 percent of adult cancers
On Feb. 5, 2025, scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and…
-
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
On Jan. 30, 2025, the U.S. Food and Drug Administration (FDA) approved Vertex Pharmaceuticals’s Journavx (suzetrigine) 50 milligram…
-
A genome-wide atlas of cell morphology revealed gene functions
On Jan. 27, 2025, researchers at the Broad Institute of MIT and Harvard, along with collaborators at Calico…
-
PET probe images inflammation with high sensitivity and selectivity
On Jan. 22, 2025, researchers at Dana-Farber Cancer Institute announced they have developed a breakthrough method to detect…
-
Biotechnology | Diagnostics | Disease | Medicine | Oncology | Therapeutics
Massachusetts General Hospital Received Transformational Gift of $100 Million from Herb Chambers to Revolutionize Cancer Care for Patients and Families
On Dec. 11, 2024, Massachusetts General Hospital (MGH), founding member of the Mass General Brigham healthcare system, announced…
-
Massachusetts Governor Announced More than $21 Million in Tax Incentives for 19 Life Sciences Companies
On Oct. 15, 2024, Massachusetts Governor Maura Healey and the Massachusetts Life Sciences Center (MLSC) announced $21.4 million…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Neurology | NIH | Non-Profit Research | Therapeutics | Vaccine
Study Found Persistent Infection Could Explain Long COVID in Some People
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
-
Nobel Prize in Physiology or Medicine awarded to Victor Ambros and Gary Ruvkun
On Oct. 7, 2024, The Nobel Foundation announced that Victor Ambros from Harvard University and Gary Ruvkun from…
-
Researchers used AI to Repurpose Existing Drugs for Treatment of Rare Diseases
On Sept. 25, 2024, a study led by scientists at Harvard Medical School announced they had developed an…
-
National Academies reported COVID-19 vaccines don’t cause many potential harms
On Apr. 16, 2024, the National Academies of Sciences, Engineering, and Medicine reported that the COVID-19 vaccines made…
-
Moderna to make milestone payments to NIH for COVID vaccine
On Feb. 24, 2023, Moderna announced will make certain contingent development, commercial and regulatory milestone payments to the…
-
Moderna finalized strategic partnership with UK government
On Dec. 21, 2022, Moderna announced the the finalization of a strategic partnership with the United Kingdom (UK)…
-
Moderna received FDA EUA for Omicron-targeting bivalent COVID-19 booster vaccine in children 6 months through 5 years of age
On Dec. 8, 2022, Moderna announced it had received emergency use authorization from the U.S. Food and Drug…
-
Japan approved partial change to a NDA for Omicron-targeting bivalent booster COVID-19 vaccine
On Oct. 31, 2022, Moderna announced that it had received approval from the Ministry of Health, Labour and…
-
U.S. FDA recommended Novavax COVID-19 vaccine, adjuvanted as a booster in adults
On Oct. 19, 2022, the U.S. Food and Drug Administration (FDA) recommended the use of the Novavax COVID-19…
-
EMA’s CHMP for Human Use issued positive opinion recommending authorization for use of Spikevax in children 6 months – 5 years in EU
On Oct. 19, 2022, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
-
90-Day analysis showed Moderna’s Omicron BA.1-targeting bivalent vaccine, mRNA-1273.214, demonstrated superior antibody response
On Oct. 19, 2022, Moderna announced new clinical data on its bivalent Omicron-containing booster, mRNA-1273.214. Ninety days after…
-
Moderna announced supply agreement with Gavi that secured access to updated variant-specific COVID-19 vaccines for low-and-middle income countries
On Oct. 17, 2022, Moderna and Gavi, the Vaccine Alliance, announced they had mutually agreed to cancel remaining…
-
Moderna received Authorization for Emergency Use from FDA of Omicron-targeting bivalent COVID-19 booster vaccine for children
On Oct. 12, 2022, Moderna announced that it had received emergency use authorization from the U.S. Food and…
-
Biotechnology | CRISPR | Disease | Genomics | Therapeutics
U.S. patent appeal board ruled against University of California in CRISPR interference
On Feb. 28, 2022, the Patent and Trial Appeal Board of the U.S. Patent and Trademark Office (USPTO)…
-
EMA’s Committee for Medicinal Products for Human Use recommended authorization of Covid-19 vaccine in children (6-11 Years) In the EU
On Feb. 24, 2022, Moderna announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use…
-
Moderna expanded global footprint through commercial partnership with Adium in Latin America
On Feb. 22, 2022, Moderna announced a distribution service agreement with Adium Pharma, a leading private Latin American…
-
Therapeutic Goods Administration of Australia authorized Moderna’s Covid-19 vaccine in children (6-11 Years)
On Feb. 16, 2022, Moderna announced that the Therapeutic Goods Administration in Australia had granted provisional registration for…
-
Moderna announced new supply agreement with Colombia for additional 10.8 million doses of COVID-19 vaccine
On Feb. 8, 2022, Moderna announced a new supply agreement with the government of Colombia for 10.8 million…
-
CDC’s ACIP issued recommendation for use of Moderna COVID-19 vaccine in adults aged =18 years
On Feb. 4, 2022, the Advisory Committee on Immunization Practices (ACIP) issued a standard recommendation for use of…
-
Moderna received full U.S. FDA approval for COVID-19 vaccine Spikevax
On Jan. 31, 2022, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the Biologics License…
-
Moderna announced first participant dosed in phase 2 study of Omicron-specific booster candidate and publication of data
On Jan. 26, 2022, Moderna announced that the first participant had been dosed in the Phase 2 study…
